• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

2026 AGM Information

Notice of Annual General Meeting

This is a notice regarding the International Alliance of ALS/MND Associations’ Annual General Meeting (AGM), taking place virtually via Zoom.

Date: Tuesday, November 24, 2026
Time: 9:00–10:00 am EST 
Zoom link: To be confirmed

We value our members’ input. If you’d like to submit an agenda item, please use the links below to fill out a form.

  • Call for Agenda Items (member login required)
  • Call for Resolutions (member login required)

The deadline to submit agenda items and resolutions is October 8, 2026.

Thank you to our members who submitted a nomination for the Board of Directors. Nominations are now closed. Electronic voting will be sent to Alliance delegates who are eligible for voting shortly.

The AGM agenda along with the Annual Report and Financial Statements will be distributed before the meeting. 

Voting

Voting will be conducted by a show of hands from virtual participants at the meeting. 

The items under vote will be shared before the meeting.

Questions

The Alliance welcomes your questions in advance of the AGM. Please send them to cathy.cummings@als-mnd.org. You will also have the opportunity to ask questions during the AGM. 

Proxy Vote Instructions & Form

  1. As a member of the Charity, you are entitled to appoint a proxy to exercise all or any of your rights to attend, speak, and vote at the meeting.
  2. You can only appoint a proxy using the procedures set out in these notes.
  3. A proxy must be an authorized representative of the member (no other individuals are permitted to be proxies) and must attend the meeting to represent you.
  4. If no voting indication is given, your proxy will vote or abstain from voting on the resolutions put to the meeting at their discretion.
  5. Unless the proxy appointment indicates otherwise, it will be treated as:
    • allowing your proxy to vote (or abstain from voting) as they see fit in relation to the limited range of additional resolutions which may be put before the meeting; and
    • appointing your proxy in relation to any adjournment of the meeting.
  6. Proxy appointments must be made using the form below or in writing and emailed to the Secretary of the Charity, Catherine Cummings, at cathy.cummings@als-mnd.org.
  7. The proxy appointments must be notified to the Secretary of the Charity before the commencement of the meeting.
  8. If you are completing the proxy appointment under the authority of a power of attorney or any other authority, you must send the relevant document or a certified copy to the Secretary of the Charity when you return the proxy appointment.
  9. If you wish to change your proxy instructions, you may submit another appointment in the way indicated above. The appointment received last before the latest time for the receipt of proxies will take precedence.
  10. If you wish to revoke your proxy instructions, you may send a notice to the Secretary of the Charity in any of the ways described at note 6 above clearly stating that the instructions are revoked. The revocation must be received by the Secretary of the Charity no later than the commencement of the meeting.
  11. Appointment of a proxy does not preclude you from attending the meeting and voting yourself. If you have appointed a proxy and you attend the meeting and cast a vote yourself, your proxy is no longer entitled to vote on your behalf.
  12. You may only communicate with the Charity about the meeting and appointing a proxy for the meeting using the addresses at note 6. No other methods of communication will be accepted.

2026 Proxy Form

As a member of the Charity, you are entitled to appoint a proxy through this form to exercise all or any of your rights to attend, speak and vote at the meeting.

This field is hidden when viewing the form

2026 Proxy Form

It is the responsibility of the member to determine whether the person to whom they assign the proxy is able and agrees to act in the manner described. Please ensure submission of the completed proxy to the International Alliance of ALS/MND Associations no later than November 17, 2026, at 5:00 pm ET.
Your Name(Required)
I, a voting member in good standing of the International Alliance of ALS/MND Associations, hereby appoint the following person as my proxy to attend, act, and vote on my behalf at the Annual General Meeting of members to be held virtually on November 24, 2026, at 9:00 am ET (including adjournments thereof).(Required)
Failing the person named above, I hereby give my proxy to the following person.(Required)
OR (complete only if you wish to name someone other than the above as your proxy) I hereby appoint the following person, a voting member in good standing, as my proxy to attend, act, and vote on my behalf at the Annual General Meeting of members to be held virtually on November 24, 2026, at 9:00 am ET (including adjournments thereof).
By completing the following boxes, the signing party listed below digitally confirms the proxy appointment.

Primary Sidebar

  • Greg Heydet, USA

    Greg Heydet, USA

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • John Dinon, Australia

    John Dinon, Australia

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Mike Cels, Canada

    Mike Cels, Canada

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Phil Rossall, UK

    Phil Rossall, UK

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Steve

    Steve

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Jason Goodman, USA

    Jason Goodman, USA

  • Art Eggert, USA

    Art Eggert, USA

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Ali Var, Turkey

    Ali Var, Turkey

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Rob Tison, USA

    Rob Tison, USA

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • John Russo, USA

    John Russo, USA
    final3878

  • Hollister

    Hollister
    hollister

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login